Nu Skin enters research agreements
This article was originally published in The Rose Sheet
Executive Summary
Direct seller of anti-aging products has entered into research agreements with Stanford University and Madison, Wis.-based LifeGen Technologies to improve its understanding of the genetic basis of aging. In an Oct. 22 release, the firm says its agreement with Stanford "aims to increase the understanding of fundamental aging mechanisms" and includes access to the university's expertise in dermatological clinical trials. The exclusive agreement with LifeGen will "leverage LifeGen's proprietary methods regarding gene expression profiling and pathways affected by aging." The relationships will "help us develop next-generation skin care and nutritional products," says Joseph Chang, Nu Skin chief scientific officer and executive VP of product development. Provo, Utah-based Nu Skin sells its personal-care products - including cosmetics, hair care and fragrances - in 48 international markets through more than 750,000 independent sales representatives. In 2010, it plans to expand its ageLOC anti-aging line with nutritional supplements (1"The Rose Sheet" June 29, 2009)